Published in Environ Toxicol Pharmacol on April 01, 2013
Influence of phthalates on in vitro innate and adaptive immune responses. PLoS One (2015) 0.78
Phthalate esters affect maturation and function of primate testis tissue ectopically grafted in mice. Mol Cell Endocrinol (2014) 0.77
Influence of phthalates on cytokine production in monocytes and macrophages: a systematic review of experimental trials. PLoS One (2015) 0.76
Hepatitis C virus infection in an endemic area of Southern Italy 14 years later: evidence for a vanishing infection. Dig Liver Dis (2012) 1.55
Prospective randomized double-blind trial of racecadotril compared with loperamide in elderly people with gastroenteritis living in nursing homes. Eur J Clin Pharmacol (2009) 1.50
Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis. J Res Med Sci (2012) 1.47
Determinants of health-related quality of life in pharmacoresistant epilepsy: results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments. Epilepsia (2011) 1.20
Adverse effects of atypical antipsychotics in the elderly: a review. Drugs Aging (2006) 1.15
Glutamate metabotropic receptors as targets for drug therapy in epilepsy. Eur J Pharmacol (2003) 1.13
Comparison of the antiepileptogenic effects of an early long-term treatment with ethosuximide or levetiracetam in a genetic animal model of absence epilepsy. Epilepsia (2009) 1.11
Novel potent anticonvulsant agent containing a tetrahydroisoquinoline skeleton. J Med Chem (2006) 1.06
The cAMP-HMGA1-RBP4 system: a novel biochemical pathway for modulating glucose homeostasis. BMC Biol (2009) 1.04
Mast cell positivity to tryptase correlates with metastatic lymph nodes in gastrointestinal cancer patients treated surgically. Oncology (2013) 1.03
Hypericum perforatum: pharmacokinetic, mechanism of action, tolerability, and clinical drug-drug interactions. Phytother Res (2013) 1.03
Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy. Neuropharmacology (2012) 1.03
Hypolipemic and hypoglycaemic activity of bergamot polyphenols: from animal models to human studies. Fitoterapia (2010) 1.02
Anticonvulsant effects of carbenoxolone in genetically epilepsy prone rats (GEPRs). Neuropharmacology (2004) 1.01
Comparative anticonvulsant activity of some 2,3-benzodiazepine derivatives in rodents. Pharmacol Biochem Behav (2003) 1.01
Hepatotoxicity induced by methimazole in a previously healthy patient. Curr Drug Saf (2009) 0.99
Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy. Epilepsia (2010) 0.99
Interactions among Low Dose of Methotrexate and Drugs Used in the Treatment of Rheumatoid Arthritis. Adv Pharmacol Sci (2013) 0.96
Antiabsence effects of carbenoxolone in two genetic animal models of absence epilepsy (WAG/Rij rats and lh/lh mice). Neuropharmacology (2005) 0.96
The mTOR signaling pathway in the brain: focus on epilepsy and epileptogenesis. Mol Neurobiol (2012) 0.95
Nonpsychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability. ACS Chem Neurosci (2014) 0.93
Lack of efficacy during the switch from brand to generic allopurinol. J Forensic Leg Med (2013) 0.92
Tryptase-positive mast cells and angiogenesis in keloids: a new possible post-surgical target for prevention. Updates Surg (2012) 0.92
Effects of early long-term treatment with antiepileptic drugs on development of seizures and depressive-like behavior in a rat genetic absence epilepsy model. Epilepsia (2011) 0.91
Seizure susceptibility to various convulsant stimuli in dystrophin-deficient mdx mice. Neurosci Res (2004) 0.91
mTOR inhibition modulates epileptogenesis, seizures and depressive behavior in a genetic rat model of absence epilepsy. Neuropharmacology (2012) 0.91
Abatacept improves whole-body insulin sensitivity in rheumatoid arthritis: an observational study. Medicine (Baltimore) (2015) 0.89
Asterixis as a presentation of cerebellar ischemic stroke. West J Emerg Med (2012) 0.88
Solution-phase parallel synthesis of novel 1,2,3,4-tetrahydroisoquinoline-1-ones as anticonvulsant agents. Chem Pharm Bull (Tokyo) (2008) 0.88
The antidote effect of quinone oxidoreductase 2 inhibitor against paraquat-induced toxicity in vitro and in vivo. Br J Pharmacol (2013) 0.88
Use and safety of antipsychotics in behavioral disorders in elderly people with dementia. J Clin Psychopharmacol (2014) 0.88
Influence of carbenoxolone on the anticonvulsant efficacy of conventional antiepileptic drugs against audiogenic seizures in DBA/2 mice. Eur J Pharmacol (2004) 0.87
Venlafaxine-propafenone interaction resulting in hallucinations and psychomotor agitation. Ann Pharmacother (2008) 0.87
Cerebral stroke injury: the role of cytokines and brain inflammation. J Basic Clin Physiol Pharmacol (2014) 0.86
Phenobarbital/Lamotrigine coadministration-induced blood dyscrasia in a patient with epilepsy. Ann Pharmacother (2010) 0.86
Prevalence of Undiagnosed Diabetes in Rheumatoid Arthritis: an OGTT Study. Medicine (Baltimore) (2016) 0.86
Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice. Pharmacol Res (2011) 0.85
Epilepsy-induced abnormal striatal plasticity in Bassoon mutant mice. Eur J Neurosci (2009) 0.85
Anticonvulsant profile of flunarizine and relation to Na(+) channel blocking effects. Basic Clin Pharmacol Toxicol (2004) 0.85
Ameliorating effects of aripiprazole on cognitive functions and depressive-like behavior in a genetic rat model of absence epilepsy and mild-depression comorbidity. Neuropharmacology (2012) 0.85
Immunohistochemical analysis of the ubiquitin-conjugating enzyme UbcH10 in lung cancer: a useful tool for diagnosis and therapy. J Histochem Cytochem (2012) 0.85
Seizure susceptibility to various convulsant stimuli of knockout interleukin-6 mice. Pharmacol Biochem Behav (2004) 0.85
Rosacea-like facial rash related to metformin administration in a young woman. BMC Pharmacol Toxicol (2014) 0.85
AMPA receptor antagonists as potential anticonvulsant drugs. Curr Top Med Chem (2005) 0.85
Neuropharmacology of depression in aging and age-related diseases. Ageing Res Rev (2002) 0.84
Efficacy and safety of off-label use of fondaparinux in the management of heparin-induced thrombocytopenia with thrombosis in an elderly woman. J Clin Pharmacol (2013) 0.84
Spinal myoclonus responsive to topiramate. Mov Disord (2004) 0.84
PPH vs Milligan-Morgan: early and late complications in the treatment of haemorrhoidal disease with circumferential prolapse. Ann Ital Chir (2013) 0.84
Effects of ethanol on the development of genetically determined epilepsies in rats. Int J Dev Neurosci (2008) 0.83
A case of neuroleptic malignant syndrome induced by risperidone in a schizophrenic woman. Curr Drug Saf (2009) 0.83
Effects of acetaminophen and ibuprofen in children with migraine receiving preventive treatment with magnesium. Headache (2013) 0.83
New evidence for a critical role of elastin in calcification of native heart valves: immunohistochemical and ultrastructural study with literature review. Histopathology (2011) 0.83
Use of topiramate for glossodynia. Pain Med (2007) 0.83
Pharmacodynamic potentiation of antiepileptic drugs' effects by some HMG-CoA reductase inhibitors against audiogenic seizures in DBA/2 mice. Pharmacol Res (2012) 0.83
Macrophage autophagy and oxidative stress: an ultrastructural and immunoelectron microscopical study. Oxid Med Cell Longev (2011) 0.81
Increase in plasma homocysteine levels induced by drug treatments in neurologic patients. Pharmacol Res (2005) 0.81
Levofloxacin-induced taste perversion, blurred vision and dyspnoea in a young woman. Clin Drug Investig (2004) 0.81
A comprehensive safety evaluation of trabectedin and drug-drug interactions of trabectedin-based combinations. BioDrugs (2014) 0.81
Synthesis and anticonvulsant activity of novel bicyclic acidic amino acids. J Med Chem (2003) 0.81
A review on antiepileptic drugs-dependent fatigue: pathophysiological mechanisms and incidence. Eur J Pharmacol (2013) 0.81
Cocaine dependence and stroke: pathogenesis and management. Curr Neurovasc Res (2015) 0.80
The safety of clozapine in the elderly. Expert Opin Drug Saf (2008) 0.80
A questionnaire-based study on prevalence and treatment of headache in young children. J Headache Pain (2005) 0.80
Effects of carbamazepine/oxycodone coadministration in the treatment of trigeminal neuralgia. Ann Pharmacother (2011) 0.80
Vigabatrin has antiepileptogenic and antidepressant effects in an animal model of epilepsy and depression comorbidity. Behav Brain Res (2011) 0.80
Effects of some neurosteroids injected into some brain areas of WAG/Rij rats, an animal model of generalized absence epilepsy. Neuropharmacology (2006) 0.80
Anti-inflammatory Strategies in Stroke: a Potential Therapeutic Target. Curr Vasc Pharmacol (2016) 0.80
Altered distribution and function of A2A adenosine receptors in the brain of WAG/Rij rats with genetic absence epilepsy, before and after appearance of the disease. Eur J Neurosci (2009) 0.80
Chronic inflammatory diseases: do immunological patterns drive the choice of biotechnology drugs? A critical review. Autoimmunity (2014) 0.79
Susceptibility to audiogenic seizure and neurotransmitter amino acid levels in different brain areas of IL-6-deficient mice. Pharmacol Biochem Behav (2004) 0.79
Melaena following Use of the Cholinesterase Inhibitor Rivastigmine. Clin Drug Investig (2005) 0.79
New AMPA antagonists in epilepsy. Expert Opin Investig Drugs (2012) 0.79
Conventional and atypical antipsychotics in the elderly : a review. Clin Drug Investig (2003) 0.79
Palmitoylethanolamide modulates pentobarbital-evoked hypnotic effect in mice: involvement of allopregnanolone biosynthesis. Eur Neuropsychopharmacol (2009) 0.79
Neuroactive steroids and GABAA receptor plasticity in the brain of the WAG/Rij rat, a model of absence epilepsy. J Neurochem (2008) 0.79
Effects of non-competitive AMPA receptor antagonists injected into some brain areas of WAG/Rij rats, an animal model of generalized absence epilepsy. Neuropharmacology (2006) 0.79
Role of CYP3A5 in abnormal clearance of methadone. Ann Pharmacother (2008) 0.78
New 7,8-ethylenedioxy-2,3-benzodiazepines as noncompetitive AMPA receptor antagonists. Bioorg Med Chem Lett (2005) 0.78
Preclinical activity profile of α-lactoalbumin, a whey protein rich in tryptophan, in rodent models of seizures and epilepsy. Epilepsy Res (2011) 0.78